01
Cash & equivalents increased 38.3%
Cash & equivalents changed +38.3% from the comparable as-filed period.
$62.2M→$86.1MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTPRECISION BIOSCIENCES INC's latest supported as-filed period reports revenue of $0, 100.0% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +38.3% from the comparable as-filed period.
Net income changed -38.8% from the comparable as-filed period.
Operating income changed +12.4% from the comparable as-filed period.
Operating margin moved -121587.28 percentage points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
DTIL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001628280-26-058512SEC ↗10-QAug 6, 2026Period Jun 30, 20260001628280-26-053837SEC ↗8-KAug 6, 2026Period Aug 6, 20260001628280-26-053836SEC ↗8-KJul 27, 2026Period Jul 23, 20260001628280-26-049665SEC ↗8-KJul 1, 2026Period Jul 1, 20260001628280-26-046340SEC ↗8-KJun 16, 2026Period Jun 10, 20260001628280-26-043526SEC ↗4Jun 5, 2026Period Jun 3, 20260001628280-26-041045SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 3, 2026Filed Jun 5, 2026 | Brown MelindaDirector | Grant Or AwardDirect | 20,979 | $0 | $0 | Form 4 ↗ |
| Jun 3, 2026Filed Jun 5, 2026 | Frankel StanleyDirector | Grant Or AwardDirect | 20,979 | $0 | $0 | Form 4 ↗ |
| Jun 3, 2026Filed Jun 5, 2026 | Germano Geno JDirector | Grant Or AwardDirect | 20,979 | $0 | $0 | Form 4 ↗ |
| Jun 3, 2026Filed Jun 5, 2026 | Pire Shari LisaDirector | Grant Or AwardDirect | 20,979 | $0 | $0 | Form 4 ↗ |
| Jun 3, 2026Filed Jun 5, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -2.9% from the comparable as-filed period.
Revenue changed -100.0% from the comparable as-filed period.
Stock-based compensation changed -37.2% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001628280-26-041043| Grant Or AwardDirect |
| 20,979 |
| $0 |
| $0 |
| Form 4 ↗ |
| Jun 1, 2026Filed Jun 3, 2026 | SMITH J. JEFFERSONChief Research Officer | Grant Or AwardDirect | 57,389 | $0 | $0 | Form 4 ↗ |
| Jun 1, 2026Filed Jun 3, 2026 | Scimeca DarioGeneral Counsel and Secretary | Grant Or AwardDirect | 107,604 | $0 | $0 | Form 4 ↗ |
| Jun 1, 2026Filed Jun 3, 2026 | Kelly John AlexanderChief Financial Officer | Grant Or AwardDirect | 193,688 | $0 | $0 | Form 4 ↗ |
| Jun 1, 2026Filed Jun 3, 2026 | Amoroso MichaelPresident and CEO | Grant Or AwardDirect | 573,888 | $0 | $0 | Form 4 ↗ |
| May 20, 2026Filed May 22, 2026 | Buehler KevinDirector | Option ExerciseDirect | 21,000 | — | — | Form 4 ↗ |
| May 20, 2026Filed May 22, 2026 | Buehler KevinDirector | Option ExerciseDirect | 21,000 | $0 | $0 | Form 4 ↗ |
| May 20, 2026Filed May 22, 2026 | Frankel StanleyDirector | Option ExerciseDirect | 21,000 | — | — | Form 4 ↗ |
| May 20, 2026Filed May 22, 2026 | Frankel StanleyDirector | Option ExerciseDirect | 21,000 | $0 | $0 | Form 4 ↗ |
| May 20, 2026Filed May 22, 2026 | Brown MelindaDirector | Option ExerciseDirect | 21,000 | — | — | Form 4 ↗ |
| May 20, 2026Filed May 22, 2026 | Brown MelindaDirector | Option ExerciseDirect | 21,000 | $0 | $0 | Form 4 ↗ |